The effects of esketamine and treatment expectation in acute major depressive disorder (Expect): study protocol for a pharmacological fMRI study using a balanced placebo design.
Irina FalkenbergFlorian BitschWei LiuAlexandros MatsingosLaila NoorChristoph VogelbacherCüneyt YildizTilo KircherPublished in: Trials (2023)
This trial has been prospectively registered with the EU Clinical Trials Register: EudraCT-No.: 2020-000784-23 (November 17, 2020).